TABLE 2. Evolution of glycemia and lipid profile indicators at the preoperative and 1, 2, 3, 4, 5 and 10 years after Roux-en y gastric bypass.

		Glycemia			TC			TG			LDLc			HDLc
		(mg/dl)			(mg/dl)			(mg/dl)			(mg/dl)			(mg/dl)
	n	Mean±SD	(%)	n	Mean±SD	(%)	n	Mean±SD	(%)	n	Mean±SD	(%)	n	Mean±SD	(%)
Preoperative	166	108.0±38.7	40	360	182.4±40.0	31	357	146.8±73.1	38	351	114.1±33.2	29	358	40.4±10.7	31
1 year PO	161	85.1±10.5a	6.2	332	159.9±30.5a	9.3	332	86.4±34.6a	4.8	325	95.5±25.0a	8.9	326	47.2±10.0a	8
2 years PO	150	84.5±11.8a	6.7	147	165.2±33.8a	14	148	80.5±36.0a	4.1	146	94.8±26.8a	7.5	147	54.2±13.0a,b	3.4
3 years PO	136	83.9±9.9a	5.1	130	166.6±32.4a	12	130	78.5±33.0a	4.6	130	98.1±27.1a	10	130	53.3±11.4a,b	3.8
4 years PO	104	84.6±11.5a	5.8	100	174.9±37.8b,c	27	100	81.9±38.3a	9	101	103.8±29.9a,b,c	19	101	54.3±12.6a,b	5.9
5 years PO	64	83.9±13.2a	4.7	61	175.3±37.0b	23	62	75.8±29.8a	3.2	62	105.5±29.6a,b,c	18	62	54.5±12.1a,b	3.2
10 years PO	27	85.1±7.9a	3.7	27	164.2±50.2	29.6	27	81.4±36.4a	7.4	27	98.1±32.3	29.6	27	54.7±14.9a	7.4

PO=postoperative time; n=number of patients evaluated; (%)=percentage of patients with values outside the normal range; TC=total cholesterol total; LDLc=low density lipoprotein; HDLc=high density lipoprotein; TG=triglycerides; a=p<0.05 compared to preoperative; b=p<0.05 compared to one year PO; c=p<0.05 compared to two years PO